THE EVALUATION OF SERUM ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) LEVELS AND ITS RELATIONSHIP WITH CLINICAL OUTCOME IN PATIENTS WITH COVID-19

被引：0
|
作者：
Hosseinib, M. [1 ]
Hashemi-Bajgani, S. -M. [2 ,3 ]
Fekri, M. Samareh [1 ,2 ,4 ]
机构：
[1] Kerman Univ Med Sci, Afzalipour Hosp, Dept Internal Med, Sch Med, Kerman, Iran
[2] Kerman Univ Med Sci, Afzalipour Hosp, Kerman, Iran
[3] Sch Med, Dept Internal Med 1, Yazd, Iran
[4] Sch Med, Dept Internal Med 1, Kerman, Iran
来源：
CHEST | 2022年 / 161卷 / 06期
关键词：
Angiotensin-converting enzyme 2 (ACE2);
D O I：
10.1016/j.chest.2022.04.063
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：529A / 529A
页数：1
相关论文
共 50 条
  • [1] The evaluation of Serum angiotensin-converting enzyme 2 (ACE2) levels and its relationship with clinical outcome in patients with Coronavirus disease 2019 (COVID-19)
    Hashemi-Bajgani, S.
    Fekri, M. Samareh
    Hosseinib, M.
    Baniasad, A.
    Behzadi, A.
    Movahedinia, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
    Wentao Ni
    Xiuwen Yang
    Deqing Yang
    Jing Bao
    Ran Li
    Yongjiu Xiao
    Chang Hou
    Haibin Wang
    Jie Liu
    Donghong Yang
    Yu Xu
    Zhaolong Cao
    Zhancheng Gao
    Critical Care, 24
  • [3] Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
    Ni, Wentao
    Yang, Xiuwen
    Yang, Deqing
    Bao, Jing
    Li, Ran
    Xiao, Yongjiu
    Hou, Chang
    Wang, Haibin
    Liu, Jie
    Yang, Donghong
    Xu, Yu
    Cao, Zhaolong
    Gao, Zhancheng
    CRITICAL CARE, 2020, 24 (01)
  • [4] Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
    Kuba, Keiji
    Yamaguchi, Tomokazu
    Penninger, Josef M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research
    Omar, Michael Brandon
    HEART & LUNG, 2020, 49 (04): : 351 - 351
  • [6] Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
    Gomez, Juan
    Albaiceta, Guillermo M.
    Garcia-Clemente, Marta
    Lopez-Larrea, Carlos
    Amado-Rodriguez, Laura
    Lopez-Alonso, Ines
    Hermida, Tamara
    Enriquez, Ana I.
    Herrero, Pablo
    Melon, Santiago
    Alvarez-Argueelles, Marta E.
    Boga, Jose A.
    Rojo-Alba, Susana
    Cuesta-Llavona, Elias
    Alvarez, Victoria
    Lorca, Rebeca
    Coto, Eliecer
    GENE, 2020, 762
  • [7] Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19
    Rieder, Marina
    Wirth, Luisa
    Pollmeier, Luisa
    Jeserich, Maren
    Goller, Isabella
    Baldus, Niklas
    Schmid, Bonaventura
    Busch, Hans-Joerg
    Hofmann, Maike
    Kern, Winfried
    Bode, Christoph
    Duerschmied, Daniel
    Lother, Achim
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (03) : 278 - 281
  • [8] ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19
    Maza, Maria del Carmen
    Ubeda, Maria
    Delgado, Pilar
    Horndler, Lydia
    Llamas, Miguel A.
    van Santen, Hisse M.
    Alarcon, Balbino
    Abia, David
    Garcia-Bermejo, Laura
    Serrano-Villar, Sergio
    Bastolla, Ugo
    Fresno, Manuel
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
    Rodrigues, Rui
    Costa de Oliveira, Sofia
    MICROORGANISMS, 2021, 9 (08)
  • [10] Angiotensin-Converting Enzyme 2 (ACE2): Role in the Pathogenesis of Diseases outside of COVID-19
    Mulling, N.
    Rohn, H.
    NEPHROLOGE, 2021, 16 (03): : 185 - 188
12345